You have read all your free articles, to continue reading subscribe to read the rest of this content.
NextCell Pharma has announced that a patent application has been filed for the treatment of Sars-CoV-2 mediated severe pneumonia with ProTrans. NextCell increases the IP protection for the drug candidate ProTrans for the treatment of autoimmune diseases and inflammatory conditions. The latest patAlready a subscriber Login You have read all…
New results from the TACKLE Phase III COVID-19 treatment trial showed that AZD7442, a long acting antibody (LAAB) combination, achieved a statistically significant reduction in severe COVID-19 or death compared to placebo in non-hospitalized patients with mild-to-moderate symptomatic COVID-19. ThAlready a subscriber Login You have read all your free articles,…
The Phase 2 Covid-19 trial of Rabeximod that has been conducted in Eastern Europe during Q1-Q2 2021 will be closed as the trial has been shown to have a sufficient number of patients enrolled to allow for statistical analysis. Recently Cyxone reported that patient recruitment for the clinical stuAlready a…
Valneva Sweden, currently manufacturing the cholera vaccine DUKORAL, is preparing to perform part of the production of the company’s COVID-19 vaccine, VLA2001, currently the only inactivated COVID-19 vaccine in clinical development in Europe. “Inactivated virus vaccines are historically one of Already a subscriber Login You have read all your free…
